Amy C Schefler
About
In The Last Decade
Amy C Schefler
84 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 66
- Ophthalmology 1.0k
- Radiology, Nuclear Medicine and Imaging 338
- Oncology 284
- Molecular Biology 236
- Pulmonary and Respiratory Medicine 234
Countries citing papers authored by Amy C Schefler
This map shows the geographic impact of Amy C Schefler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C Schefler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C Schefler more than expected).
Fields of papers citing papers by Amy C Schefler
This network shows the impact of papers produced by Amy C Schefler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C Schefler. The network helps show where Amy C Schefler may publish in the future.
Co-authorship network of co-authors of Amy C Schefler
This figure shows the co-authorship network connecting the top 25 collaborators of Amy C Schefler. A scholar is included among the top collaborators of Amy C Schefler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C Schefler. Amy C Schefler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | Two year results of a phase 1b/2 open-label clinical trial of AU-011 for the treatment of small to medium choroidal melanoma | 2 |
| 7 | 11 | |
| 8 | 25 | |
| 9 | 1 | |
| 10 | 17 | |
| 11 | Ocriplasmin for Vitreomacular Adhesion (VMA) in the Clinical Setting: Rates of VMA Release, Development of Macular Holes, and Visual Outcomes | 2 |
| 12 | 6 | |
| 13 | Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration | 5 |
| 14 | Retinoblastoma Molecular Genomics: Regional Differences in the Molecular Genomics Expression Following Treatment With 2-Deoxy-D-Glucose in LHBETATAG Retinal Tumors | 1 |
| 15 | Supraselective Intra-Ophthalmic Artery Chemotherapy: Evaluation of Treatment Related Complications in Advanced Retinoblastoma | 1 |
| 16 | 14 | |
| 17 | 1 | |
| 18 | 5 | |
| 19 | Echographic Features of Melanocytoma Detected by Standard and High–Resolution Ultrasound | 1 |
| 20 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.